Titan Biotech Reports Strong Q2 FY27 Consolidated Net Profit Growth of 61.6% YoY
Titan Biotech Ltd · Outcome · 05 Nov 2026, 9:21 pm
Titan Biotech Reports Strong Q2 FY27 Consolidated Net Profit Growth of 61.6% YoY Titan Biotech reported consolidated revenue from operations of ₹76.46 cr for the quarter ended 30th Sep'26, up 40.7% YoY from ₹54.35 cr and 29.2% QoQ from ₹59.17 cr. Consolidated profit before tax rose 64.1% YoY to ₹15.13 cr. Net profit attributable to shareholders increased 61.6% YoY to ₹12.55 cr compared to ₹7.76 cr in the year-ago period, yielding a basic EPS of ₹3.04. For H1 ended 30th Sep'26, operating cash flows stood at ₹12.88 cr, while consolidated net profit reached ₹23.40 cr.
Original exchange filing (PDF)
More announcements from Titan Biotech Ltd
- Unaudited Financial Results for Quarter and half year ended September 30, 2026 along with the limited review report from the Statutory Auditor. · 05 Nov 2026
- Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for .... · 05 Nov 2026
- Allotment of 1,03,29,625 Fully Paid Up Bonus Equity Shares of Rs. 2/- each to Shareholder holding shares on 23rd October, 2026 (record Date) · 26 Oct 2026
- The Company has fixed record date as Friday, October 23, 2026 for ascertaining the eligibility of Shareholders entitled for allotment of Bonus Equity Shares in the ratio of 1:4 and deemed .... · 09 Oct 2026
- Alteration of the Clause 5 i.e. Capital Clause of the Memorandum of Association (MOA) of the Company · 30 Sept 2026
- Voting results and Scrutinizers Report for 34th Annual General Meeting of the Company · 30 Sept 2026
- Proceedings of 34th Annual General Meeting of Titan Biotech Limited · 30 Sept 2026
- The Company has sent Letters to those members who have not registered their email address with the Company/RTA/ Depository providing a weblink including exact path of Website to access .... · 05 Sept 2026
